149 related articles for article (PubMed ID: 32747344)
1. Can β2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs.
Riiser A; Stensrud T; Stang J; Andersen LB
Br J Sports Med; 2020 Nov; 54(22):1351-1359. PubMed ID: 32747344
[TBL] [Abstract][Full Text] [Related]
2. Aerobic performance among healthy (non-asthmatic) adults using beta2-agonists: a systematic review and meta-analysis of randomised controlled trials.
Riiser A; Stensrud T; Stang J; Andersen LB
Br J Sports Med; 2021 Sep; 55(17):975-983. PubMed ID: 32816795
[TBL] [Abstract][Full Text] [Related]
3. β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials.
Pluim BM; de Hon O; Staal JB; Limpens J; Kuipers H; Overbeek SE; Zwinderman AH; Scholten RJ
Sports Med; 2011 Jan; 41(1):39-57. PubMed ID: 21142283
[TBL] [Abstract][Full Text] [Related]
4. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
Kindermann W
Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
[TBL] [Abstract][Full Text] [Related]
5. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
Wolfarth B; Wuestenfeld JC; Kindermann W
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
[TBL] [Abstract][Full Text] [Related]
6. Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance.
Kalsen A; Hostrup M; Bangsbo J; Backer V
Scand J Med Sci Sports; 2014 Oct; 24(5):814-22. PubMed ID: 23834392
[TBL] [Abstract][Full Text] [Related]
7. Inhaled beta2 agonists and performance in competitive athletes.
Kindermann W; Meyer T
Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
[TBL] [Abstract][Full Text] [Related]
8. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.
Craig SS; Dalziel SR; Powell CV; Graudins A; Babl FE; Lunny C
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012977. PubMed ID: 32767571
[TBL] [Abstract][Full Text] [Related]
9. Beta2-Agonist Doping Control and Optical Isomer Challenges.
Jacobson GA; Fawcett JP
Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
[TBL] [Abstract][Full Text] [Related]
10. Anabolic and lipolytic actions of beta
Hostrup M; Jacobson GA; Jessen S; Lemminger AK
Drug Test Anal; 2020 May; 12(5):597-609. PubMed ID: 31960603
[TBL] [Abstract][Full Text] [Related]
11. Acute supra-therapeutic oral terbutaline administration has no ergogenic effect in non-asthmatic athletes.
Sanchez AM; Borrani F; Le Fur MA; Le Mieux A; Lecoultre V; Py G; Gernigon C; Collomp K; Candau R
Eur J Appl Physiol; 2013 Feb; 113(2):411-8. PubMed ID: 22767151
[TBL] [Abstract][Full Text] [Related]
12. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.
Travers AH; Jones AP; Camargo CA; Milan SJ; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010256. PubMed ID: 23235686
[TBL] [Abstract][Full Text] [Related]
13. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
14. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
[TBL] [Abstract][Full Text] [Related]
15. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
16. Terbutaline: level the playing field for inhaled β
Jacobson GA; Hostrup M
Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883
[TBL] [Abstract][Full Text] [Related]
17. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute and 2-week administration of oral salbutamol on exercise performance and muscle strength in athletes.
Hostrup M; Kalsen A; Auchenberg M; Bangsbo J; Backer V
Scand J Med Sci Sports; 2016 Jan; 26(1):8-16. PubMed ID: 25077918
[TBL] [Abstract][Full Text] [Related]
19. Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations.
Eibye K; Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Med Sci Sports Exerc; 2013 Jan; 45(1):16-22. PubMed ID: 22843108
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids and physical performance: A systematic review with meta-analysis of randomized controlled trials.
Riiser A; Stensrud T; Andersen LB
Front Sports Act Living; 2023; 5():1108062. PubMed ID: 37033881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
